Health Canada - Federal department responsible for drug approvals and health regulation in Canada
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| PEROXIFENCE | PRODUCERS AGRI-SUPPLY LTD. | Marketed | Oct 28, 2018 | Marketed |
| ODAN-SODIUM POLYSTYRENE SULFONATE | odan laboratories ltd | Marketed | Oct 25, 2018 | Marketed |
| OLIMEL 7.6% E | baxter corporation | Marketed | Oct 25, 2018 | Marketed |
| JAMP-RANITIDINE | Jamp Pharma Corporation | Dormant | Oct 24, 2018 | Dormant |
| KADCYLA | Hoffmann-La Roche Limited | Marketed | Oct 24, 2018 | Marketed |
| JAMP-RANITIDINE | Jamp Pharma Corporation | Dormant | Oct 24, 2018 | Dormant |
| JAMP-TENOFOVIR | Jamp Pharma Corporation | Marketed | Oct 24, 2018 | Marketed |
| NRA-PREGABALIN | nora pharma inc | Marketed | Oct 22, 2018 | Marketed |
| NRA-PREGABALIN | nora pharma inc | Marketed | Oct 22, 2018 | Marketed |
| NRA-PREGABALIN | nora pharma inc | Marketed | Oct 22, 2018 | Marketed |
| NRA-PREGABALIN | nora pharma inc | Marketed | Oct 22, 2018 | Marketed |
| XTRA | PRODUCERS AGRI-SUPPLY LTD. | Marketed | Oct 21, 2018 | Marketed |
| MAR-METHIMAZOLE | marcan pharmaceuticals inc | Marketed | Oct 19, 2018 | Marketed |
| HEMLIBRA | Hoffmann-La Roche Limited | Marketed | Oct 19, 2018 | Marketed |
| MINT-CANDESARTAN | mint pharmaceuticals inc | Marketed | Oct 19, 2018 | Marketed |
| HEMLIBRA | Hoffmann-La Roche Limited | Marketed | Oct 19, 2018 | Marketed |
| MAR-METHIMAZOLE | marcan pharmaceuticals inc | Marketed | Oct 19, 2018 | Marketed |
| MINT-CANDESARTAN | mint pharmaceuticals inc | Marketed | Oct 19, 2018 | Marketed |
| TARO-PEMETREXED | Taro Pharmaceuticals Inc | Marketed | Oct 18, 2018 | Marketed |
| MONOFERRIC | Pharmacosmos A/S | Marketed | Oct 17, 2018 | Marketed |
